HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes.

AbstractBACKGROUND:
Gitelman syndrome (GS) and Bartter syndrome (BS) are hereditary salt-losing tubulopathies (SLTs) resulting from defects of renal proteins involved in electrolyte reabsorption, as for sodium-chloride cotransporter (NCC) and furosemide-sensitive sodium-potassium-chloride cotransporter (NKCC2) cotransporters, affected in GS and BS Type 1 patients, respectively. Currently, definitive diagnosis is obtained through expensive and time-consuming genetic testing. Urinary exosomes (UE), nanovesicles released by every epithelial cell facing the urinary space, represent an ideal source of markers for renal dysfunction and injury, because UE molecular composition stands for the cell of origin. On these assumptions, the aim of this work is to evaluate the relevance of UE for the diagnosis of SLTs.
METHODS:
UE were purified from second morning urines collected from 32 patients with genetically proven SLTs (GS, BS1, BS2 and BS3 patients), 4 with unclassified SLTs and 22 control subjects (age and sex matched). The levels of NCC and NKCC2 were evaluated in UE by SDS-PAGE/western blotting with specific antibodies.
RESULTS:
Due to their location on the luminal side of tubular cells, NCC and NKCC2 are well represented in UE proteome. The NCC signal is significantly decreased/absent in UE of Gitelman patients compared with control subjects (Mann-Whitney t-test, P < 0.001) and, similarly, the NKCC2 in those of Bartter type 1 (P < 0.001). The difference in the levels of the two proteins allows recognition of Gitelman and Bartter type 1 patients from controls and, combined with clinical data, from other Bartter patients. Moreover, the receiver operating characteristic curve analysis using UE NCC densitometric values showed a good discriminating power of the test comparing GS patients versus controls and BS patients (area under the curve value = 0.92; sensitivity 84.2% and specificity 88.6%).
CONCLUSIONS:
UE phenotyping may be useful in the diagnosis of GS and BS, thus providing an alternative/complementary, urine-based diagnostic tool for SLT patient recognition and a diagnostic guidance in complex cases.
AuthorsSamuele Corbetta, Francesca Raimondo, Silvana Tedeschi, Marie-Louise Syrèn, Paola Rebora, Andrea Savoia, Lorenza Baldi, Alberto Bettinelli, Marina Pitto
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant) Vol. 30 Issue 4 Pg. 621-30 (Apr 2015) ISSN: 1460-2385 [Electronic] England
PMID25422309 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Chemical References
  • Biomarkers
  • SLC12A1 protein, human
  • SLC12A3 protein, human
  • Solute Carrier Family 12, Member 1
  • Solute Carrier Family 12, Member 3
Topics
  • Adolescent
  • Adult
  • Bartter Syndrome (diagnosis, urine)
  • Biomarkers (urine)
  • Blotting, Western
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Exosomes (metabolism)
  • Female
  • Gitelman Syndrome (diagnosis, urine)
  • Humans
  • Male
  • Solute Carrier Family 12, Member 1 (urine)
  • Solute Carrier Family 12, Member 3 (urine)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: